AbCellera Biologics Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ABCL Nasdaq 2830 www.abcellera.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AbCellera Biologics Inc.

AbCellera Biologics Inc (ABCL) Down 23% Since Q3 2025 Results - Dec 4th, 2025 8:09 pm
SunCar Technology Group And 2 Other Penny Stocks To Consider - Nov 28th, 2025 5:04 am
Insider Spends US$178k Buying More Shares In AbCellera Biologics - Nov 28th, 2025 3:13 am
AbCellera Biologics Inc. (ABCL) is a Buy at Stifel Nicolaus despite Wider Q3 Net Loss - Nov 25th, 2025 6:16 am
Why Wall Street Maintains Buy Stance on AbCellera Biologics Inc. (ABCL) Amid Business Model Evolution? - Nov 18th, 2025 4:17 am
AbCellera Appoints Dr. Stephen Quake to its Board of Directors - Nov 10th, 2025 7:00 am
Assessing AbCellera Biologics (ABCL) Valuation Following Phase 1 Trial Progress and Clinical Milestones - Nov 9th, 2025 2:20 am
AbCellera Biologics Inc (ABCL) Q3 2025 Earnings Call Highlights: Transition to Clinical-Stage ... - Nov 6th, 2025 10:12 pm
AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Tops Revenue Estimates - Nov 6th, 2025 3:45 pm
AbCellera Reports Q3 2025 Business Results - Nov 6th, 2025 2:05 pm
AbCellera Biologics Inc. (ABCL): A Bull Case Theory - Oct 21st, 2025 8:47 pm
AbCellera (ABCL) Is Up 24.5% After Strong Q2 Revenue Beat and Advancing Clinical Pipeline - Oct 4th, 2025 6:43 am
Is ABCELLERA BIOLG (ABCL) Stock Outpacing Its Medical Peers This Year? - Sep 30th, 2025 7:40 am
AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025 - Sep 29th, 2025 2:05 pm
AbCellera Biologics Inc. (ABCL) is a Great Momentum Stock: Should You Buy? - Sep 29th, 2025 10:00 am
New CMO Appointment Strengthens AbCellera Biologics Inc. (ABCL)’s Push Into Immunology and Beyond - Sep 21st, 2025 7:26 am
AbCellera Biologics Inc. (ABCL) Appoints Chief Medical Officer - Sep 20th, 2025 12:43 am
TD Cowen Reiterates Buy Rating on ABCL After AbCellera Biologics Dosed First Participants of ABCL575 - Sep 15th, 2025 6:17 am
AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer - Sep 10th, 2025 7:07 am
3 Promising Penny Stocks With Market Caps Under $2B - Sep 10th, 2025 6:05 am